<DOC>
	<DOCNO>NCT01767597</DOCNO>
	<brief_summary>With 280 000 chronic carrier , 2,500 new annual case 1,300 death year , hepatitis B currently frequent potentially severe disease France , despite effort towards prevention effective care . In term prevention , France low immunization coverage ( 27.7 % ) high percentage people ignore HBV status ( 55 % ) , lead delay care . This partly explain poor knowledge hepatitis B infection general population underestimation health impact hepatitis B doctor health official . Until recently , national guideline govern implementation ( variable depend structure screen perform ) insufficient evaluation screening practice . Thus , data severity liver disease , indication treatment HBV-infected patient data use vaccination nonimmunized people scarce . Furthermore , HIV rapid test begin use widely , particularly address issue people come back collect result well adapt `` counsel '' , usefulness detect hepatitis B virus evaluate date . The main objective Optiscreen B Study determine benefit , , use rapid test screen tool improve diagnosis , care prevention hepatitis B . Individuals risk HBV-infection randomize 2 group , one group screen perform usual serological test second group screen base rapid test . Centers select represent diverse range health center whose aim include screen , prevention and/or vaccination .</brief_summary>
	<brief_title>Application HBV Rapid Tests Tool Wide-Use Screening</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Born country middle high HBV endemicity Parents born country middle high HBV endemicity Travellers resident country middle high HBV endemicity Blood , organ , tissue , sperm , and/or ovary donners candidate donners . Healthcare worker suspect come direct contact HBVinfected individual and/or expose blood biological product HBVinfected individual Close contact HBsAgpositive individual ( live household , sexual partner , share needle , etc . ) Individuals accidental exposure HBV Individuals multiple sexual partner Men sex men Pregnant woman Hemodialysis Individuals require immunosuppressive therapy Individuals persistently elevate transaminase level HIVpositive Intravenous drug user Age &lt; 18 year old Not capable provide informed consent Already participate multicenter validation HBV rapid test Having , possession , irrefutable result prior test hepatitis B virus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>rapid test</keyword>
	<keyword>screen</keyword>
	<keyword>ELISA</keyword>
	<keyword>hepatitis B virus</keyword>
	<keyword>access care</keyword>
</DOC>